Cambridge Healthtech Institute’s Inaugural

Accelerating Analytical Development

18-19 March 2025

 

Industry analytical groups are facing increased pressure to deliver key studies faster than ever before—and at lower costs. Cambridge Healthtech Institute’s inaugural Accelerating Analytical Development conference at Bioprocessing Summit Europe follows the 11-year success of this theme at the Boston Summit—and offers a best-practices forum in which industry scientists and managers can exchange ideas on strategies, new technologies, and the integration of analytical methods in support of these goals. For 2025, the meeting will include increased content on the current and future applications of AI and big-data powered applications in this space, developability analysis, new platforms and workflows, and exciting new developments in automation and miniaturisation of key methods and instruments.

 

Coverage will include, but is not limited to:

 

Applications of AI and Big Data in Bioprocess Analytics

  • Bench scientist impacts of data generation and curation initiatives
  • In silico CQA identification and assessment
  • Predictive methods and models for analytical characterisation

Automation & Miniaturisation

  • Best practices for translating traditional manual methods to automated/robotic systems
  • Challenges in automating sample preparation and handling
  • Closed loop experimentation to facilitate ML data generation
  • Qualification and validation of miniaturised assays in comparison with traditional approaches

Developability Impacts in Analytical Development

  • Developability evaluations for complex biologics
  • High-throughput developability analysis
  • Working with “developable” leads handed off from discovery

Platforms and Workflows

  • Adapting internal workflows to accommodate accelerated development timelines
  • Overcoming the barriers to further adoption of MAM
  • Phase-appropriate approaches to platforms and workflows

Process Analytics

  • In-process analytics for cell/gene therapies and other novel biologics
  • Novel sensor technologies
  • Regulatory compliance with real-time analytics in GMP stage

 

The deadline for priority consideration is Friday 15 September

 

All proposals are subject to review by session chairpersons and/or the Scientific Advisory Committee to ensure the overall quality of the conference program. Additionally, as per Cambridge Healthtech Institute’s policy, a select number of vendors and consultants who provide products and services will be offered opportunities for podium presentation slots based on a variety of Corporate Sponsorships.

 

Opportunities for Participation:

 


For more details on the conference, please contact:

Kent Simmons

Senior Conference Director

Cambridge Healthtech Institute

Phone: (+1) 207-329-2964

Email: mailto:ksimmons@healthtech.com

 

For sponsorship information, please contact:

 

Companies A-K

Phillip Zakim-Yacouby

Senior Business Development Manager

Cambridge Healthtech Institute

Phone: (1+) 781-247-1815

Email: pzakim-yacouby@cambridgeinnovationinstitute.com

 

Companies L-Z

Aimee Croke

Business Development Manager

Cambridge Healthtech Institute

Phone: (1+) 781-292-0777

Email: acroke@cambridgeinnovationinstitute.com